---
figid: PMC6667461__41467_2019_10914_Fig1_HTML
figlink: /pmc/articles/PMC6667461/figure/Fig1/
number: F1
caption: Overview of direct and indirect pro-allergenic immune responses to anti-ulcer
  drugs (AUD). a, f With regards to oral allergens, the gastric pH elevation by AUDs,
  most dominantly by proton-pump inhibitors (PPI) and H2 receptor antagonists (H2RA),
  leads to reduced pepsin activation and impaired food antigen degradation, enabling
  persistence of ingested epitopes and their uptake in the intestines–,,. This leads
  to formation of antigen-specifc IgE and promotion of a Th2 type dominated immune
  milieu resulting in eosinophilic inflammation and allergic symptoms,,. b–e With
  regards to directly AUD-associated innate and adjuvant immune effects, PPIs can
  (b) induce AhR-mediated mast cell activation synergizing with IgE-FcɛRI signaling
  and resulting in mediator release and enhanced CD63 expression via the S1P pathway;
  both mechanisms result in allergic symptoms manifestation; (c) H2RAs stimulate the
  release of Th2 cytokines from both monocyte and Th2 cells leading to a B-cell isotype
  switch resulting in IgG1 (mice) and IgE production (humans, mice); (d) Further,
  H2RAs promote an increase in Th2 cytokine releasing iNKT cells, particularly when
  co-exposed to lipid antigens, and increase in CD1d+ DCs via TLR2 activation; (e)
  Sucralfate, an aluminum compound, can induce IL-4 release from DCs along with IL-5,
  and caspase-dependent IL-1β secretion from monocytes promoting an isotype switch
  in B-cells into IgE production; f The resulting disturbance of gut microbiota composition,,
  additionally supports a pro-allergic Th2 milieu and enhances allergic symptoms
pmcid: PMC6667461
papertitle: Country-wide medical records infer increased allergy risk of gastric acid
  inhibition.
reftext: Galateja Jordakieva, et al. Nat Commun. 2019;10:3298.
pmc_ranked_result_index: '201180'
pathway_score: 0.6721104
filename: 41467_2019_10914_Fig1_HTML.jpg
figtitle: Overview of direct and indirect pro-allergenic immune responses to anti-ulcer
  drugs (AUD)
year: '2019'
organisms:
- Mus musculus
- Clostridioides difficile CD3
- Clostridioides difficile
- gut metagenome
- Homo sapiens
ndex: 13980ca6-de90-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6667461__41467_2019_10914_Fig1_HTML.html
  '@type': Dataset
  description: Overview of direct and indirect pro-allergenic immune responses to
    anti-ulcer drugs (AUD). a, f With regards to oral allergens, the gastric pH elevation
    by AUDs, most dominantly by proton-pump inhibitors (PPI) and H2 receptor antagonists
    (H2RA), leads to reduced pepsin activation and impaired food antigen degradation,
    enabling persistence of ingested epitopes and their uptake in the intestines–,,.
    This leads to formation of antigen-specifc IgE and promotion of a Th2 type dominated
    immune milieu resulting in eosinophilic inflammation and allergic symptoms,,.
    b–e With regards to directly AUD-associated innate and adjuvant immune effects,
    PPIs can (b) induce AhR-mediated mast cell activation synergizing with IgE-FcɛRI
    signaling and resulting in mediator release and enhanced CD63 expression via the
    S1P pathway; both mechanisms result in allergic symptoms manifestation; (c) H2RAs
    stimulate the release of Th2 cytokines from both monocyte and Th2 cells leading
    to a B-cell isotype switch resulting in IgG1 (mice) and IgE production (humans,
    mice); (d) Further, H2RAs promote an increase in Th2 cytokine releasing iNKT cells,
    particularly when co-exposed to lipid antigens, and increase in CD1d+ DCs via
    TLR2 activation; (e) Sucralfate, an aluminum compound, can induce IL-4 release
    from DCs along with IL-5, and caspase-dependent IL-1β secretion from monocytes
    promoting an isotype switch in B-cells into IgE production; f The resulting disturbance
    of gut microbiota composition,, additionally supports a pro-allergic Th2 milieu
    and enhances allergic symptoms
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP14
  - CASP1
  - CASP6
  - CASP7
  - CASP12
  - CASP10
  - CASP2
  - CASP8
  - CASP9
  - APCS
  - IL6
  - CASP3
  - TH
  - TLR2
  - IL10
  - LPL
  - MAPK3
  - CSF2
  - CASP4
  - MAPK1
  - IL13
  - IL18
  - CASP5
  - IL4
  - ulcer
  - SIP
  - Eosinophile inflammation
  - allergenic dysbalance
genes:
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: APCS
  symbol: APCS
  source: hgnc_symbol
  hgnc_symbol: APCS
  entrez: '325'
- word: IL6
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Th
  symbol: TH
  source: hgnc_symbol
  hgnc_symbol: TH
  entrez: '7054'
- word: TLR2
  symbol: TLR2
  source: hgnc_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: Lipd
  symbol: LIPD
  source: hgnc_prev_symbol
  hgnc_symbol: LPL
  entrez: '4023'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: GM-CSF
  symbol: GM-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF2
  entrez: '1437'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IL-13
  symbol: IL-13
  source: hgnc_alias_symbol
  hgnc_symbol: IL13
  entrez: '3596'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: IL-4
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: IL4
  symbol: IL4
  source: hgnc_symbol
  hgnc_symbol: IL4
  entrez: '3565'
chemicals: []
diseases:
- word: ulcer
  source: MESH
  identifier: D014456
- word: SIP
  source: ''
  identifier: ''
- word: Eosinophile inflammation
  source: MESH
  identifier: D004802
- word: allergenic dysbalance
  source: ''
  identifier: ''
figid_alias: PMC6667461__F1
redirect_from: /figures/PMC6667461__F1
figtype: Figure
---
